Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)
CNY 19.51
(1.19%)
CNY 19.51
(1.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 41.9 Million CNY | 146.35% |
| 2022 | -64.33 Million CNY | -165.14% |
| 2021 | 74.8 Million CNY | -36.85% |
| 2020 | 122.65 Million CNY | 15.06% |
| 2019 | 105.5 Million CNY | 11.3% |
| 2018 | 95.75 Million CNY | 23.81% |
| 2017 | 77.34 Million CNY | 21.39% |
| 2016 | 64.03 Million CNY | 71.77% |
| 2015 | 34.7 Million CNY | 1.83% |
| 2014 | 37.02 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 795.51 Thousand CNY | -39.06% |
| 2024 Q3 | -1.15 Million CNY | -109.39% |
| 2024 Q2 | 8.13 Million CNY | 61.84% |
| 2023 FY | - CNY | 146.35% |
| 2023 Q2 | 9.04 Million CNY | 304.28% |
| 2023 Q1 | 2.23 Million CNY | 110.42% |
| 2023 Q3 | 4.48 Million CNY | -50.41% |
| 2023 Q4 | 7.23 Million CNY | 61.4% |
| 2022 Q1 | -11.28 Million CNY | -380.05% |
| 2022 FY | - CNY | -165.14% |
| 2022 Q3 | -29.58 Million CNY | -246.82% |
| 2022 Q4 | -21.46 Million CNY | 27.44% |
| 2022 Q2 | -8.52 Million CNY | 24.39% |
| 2021 Q3 | 12.62 Million CNY | -40.46% |
| 2021 FY | - CNY | -36.85% |
| 2021 Q1 | 25.4 Million CNY | -44.12% |
| 2021 Q2 | 21.2 Million CNY | -16.54% |
| 2021 Q4 | 4.02 Million CNY | -68.09% |
| 2020 FY | - CNY | 15.06% |
| 2020 Q4 | 45.46 Million CNY | 60.79% |
| 2020 Q2 | 34.88 Million CNY | 453.85% |
| 2020 Q1 | 6.29 Million CNY | -74.1% |
| 2020 Q3 | 28.27 Million CNY | -18.95% |
| 2019 Q4 | 24.31 Million CNY | -9.69% |
| 2019 Q3 | 26.92 Million CNY | -3.41% |
| 2019 Q2 | 27.87 Million CNY | 43.36% |
| 2019 Q1 | 19.44 Million CNY | -27.17% |
| 2019 FY | - CNY | 11.3% |
| 2018 Q4 | 26.7 Million CNY | 29.98% |
| 2018 FY | - CNY | 23.81% |
| 2018 Q3 | 20.54 Million CNY | -17.97% |
| 2018 Q2 | 25.04 Million CNY | 57.9% |
| 2018 Q1 | 15.85 Million CNY | -38.68% |
| 2017 Q3 | 19.51 Million CNY | 0.0% |
| 2017 Q4 | 25.86 Million CNY | 32.5% |
| 2017 FY | - CNY | 21.39% |
| 2016 FY | - CNY | 71.77% |
| 2015 FY | - CNY | 1.83% |
| 2014 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. | 3.15 Billion CNY | 98.671% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 1.05 Billion CNY | 96.011% |
| Blue Sail Medical Co.,Ltd. | 132.74 Million CNY | 68.43% |
| Andon Health Co., Ltd. | 1.69 Billion CNY | 97.532% |
| Allmed Medical Products Co., Ltd | 409.86 Million CNY | 89.775% |
| Improve Medical Instruments Co., Ltd. | 17.73 Million CNY | -136.258% |
| Tofflon Science and Technology Group Co., Ltd. | 826.99 Million CNY | 94.933% |
| Truking Technology Limited | 585.49 Million CNY | 92.842% |
| Jiangxi Sanxin Medtec Co.,Ltd. | 336.13 Million CNY | 87.533% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd | 357.94 Million CNY | 88.292% |
| Autek China Inc. | 965.74 Million CNY | 95.661% |
| Intco Medical Technology Co., Ltd. | 1.16 Billion CNY | 96.408% |
| Winner Medical Co., Ltd. | 1.4 Billion CNY | 97.023% |
| Imeik Technology Development Co.,Ltd. | 2.2 Billion CNY | 98.097% |
| Zhonghong Pulin Medical Products Co., Ltd. | 86.58 Million CNY | 51.598% |
| Caina Technology Co., Ltd. | 161.95 Million CNY | 74.124% |